Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2016

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2016
ENANTA PHARM (NASDAQ: ENTA) Delayed: 14.06 +0.69 (5.16%)
Previous Close $13.37    52 Week High $34.49 
Open $13.22    52 Week Low $20.39 
Day High $14.12    P/E N/A 
Day Low $12.92    EPS $-3.18 
Volume 400,936